A phase II study of alternating cycles of CPT-11 and high-dose 48 hour infusion 5-FU in combination with leucovorin (HD-5-FU/LV) in no selective patients with metastatic colorectal cancer (MCRC)

G. Rosati(Azienda Ospedaliera di Cosenza), Luigi Manzione, Alfredo Rossi(Sapienza University of Rome), Angelo Dinota, Domenico Bilancia(Azienda Ospedaliera Ospedale San Carlo Borromeo), Stefano De Santis
European Journal of Cancer
September 1, 1999
Cited by 0


Related Papers